EmVenio Insights

Explore our resources, including blogs, whitepapers, press, videos, and more.

 

Webinar: Advancing Clinical Research Through Hybrid Clinical Trials and Patient Optionality

Discover an informative webinar that revolutionizes the impact of hybrid clinical trials by implementing patient-centric solutions that fast-track the development of life-changing therapies. Historically, trials necessitated in-person participation, requiring volunteers to travel to research sites. On average, travel times amounted to two hours, excluding the time spent…

The FDA’s timeline: advancing diversity in clinical trials

The United States Food and Drug Administration has issued several guidances throughout the last five years to enhance the diversity, equity, and inclusivity of clinical trials. These are significant and much-needed additions to the industry, supporting EmVenio’s mission of providing…

EmVenio Research Commits to SCRS Global Impact Partner Program

June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT)…

EmVenio Research’s May 2024 Community Engagement Highlights

Our collaboration with local organizations creates opportunity to address critical health issues and topics through the lens of clinical research, promoting wellness, and bringing value to the communities we serve. The well-being of our communities remains at the forefront. Together,…